Sex differences in neointimal hyperplasia following endeavor zotarolimus-eluting stent implantation

American Journal of Cardiology

Volumn 108, Issue 7, 2011, Pages 912-917

  Nakatani, Daisaku ^a   Ako, Junya ^a   Tremmel, Jennifer A ^a   Waseda, Katsuhisa ^a   Otake, Hiromasa ^a   Koo, Bon Kwon ^a   Miyazawa, Akiyoshi ^a   Hongo, Yoichiro ^a   Hur, Seung Ho ^a   Sakurai, Ryota ^a   Yock, Paul G ^a   Honda, Yasuhiro ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZOTAROLIMUS;

ADULT; ARTICLE; BARE METAL STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE;

ANGIOPLASTY, BALLOON, CORONARY; CALIFORNIA; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOINTIMA; PROGNOSIS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SIROLIMUS;

EID: 80052701477     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.05.019     Document Type: Article

References (30)

1. K. Kishi, Y. Hiasa, N. Suzuki, T. Takahashi, S. Hosokawa, M. Tanimoto, and R. Otani Predictors of recurrent restenosis after coronary stenting: an analysis of 197 patients J Invasive Cardiol 14 2002 187 191 (Pubitemid 34304141)
2. D. Trabattoni, A.L. Bartorelli, P. Montorsi, F. Fabbiocchi, A. Loaldi, S. Galli, P. Ravagnani, S. Cozzi, L. Grancini, A. Liverani, M.E. Leon, C. Robertson, and P. Boyle Comparison of outcomes in women and men treated with coronary stent implantation Catheter Cardiovasc Interv 58 2003 20 28 (Pubitemid 36055296)
3. A.M. Arnold, M.J. Mick, M.R. Piedmonte, and C. Simpfendorfer Gender differences for coronary angioplasty Am J Cardiol 74 1994 18 21 (Pubitemid 24196308)
4. J. Mehilli, A. Kastrati, H. Bollwein, A. Dibra, H. Schuhlen, J. Dirschinger, and A. Schomig Gender and restenosis after coronary artery stenting Eur Heart J 24 2003 1523 1530 (Pubitemid 37010583)
5. R.F. Fishman, R.E. Kuntz, J.P. Carrozza Jr, S.P. Friedrich, P.C. Gordon, C.C. Senerchia, and D.S. Baim Acute and long-term results of coronary stents and atherectomy in women and the elderly Coron Artery Dis 6 1995 159 168
6. J.D. Abbott, H.A. Vlachos, F. Selzer, B.L. Sharaf, E. Holper, R. Glaser, A.K. Jacobs, and D.O. Williams Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol 99 2007 626 631
7. E. Solinas, E. Nikolsky, A.J. Lansky, A.J. Kirtane, M.C. Morice, J.J. Popma, J. Schofer, E. Schampaert, T. Pucelikova, J. Aoki, M. Fahy, G.D. Dangas, J.W. Moses, D.E. Cutlip, M.B. Leon, and R. Mehran Gender-specific outcomes after sirolimus-eluting stent implantation J Am Coll Cardiol 50 2007 2111 2116 (Pubitemid 350117340)
8. A.J. Lansky, R.A. Costa, M. Mooney, M.G. Midei, H.K. Lui, W. Strickland, R. Mehran, M.B. Leon, M.E. Russell, S.G. Ellis, and G.W. Stone Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease J Am Coll Cardiol 45 2005 1180 1185 (Pubitemid 40523134)
9. R.H. Mehta, M.B. Leon, and M.H. Sketch Jr The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the Endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and ENDEAVOR III Am J Cardiol 100 suppl 2007 62M 70M
10. J. Fajadet, W. Wijns, G.J. Laarman, K.H. Kuck, J. Ormiston, T. Munzel, J.J. Popma, P.J. Fitzgerald, R. Bonan, and R.E. Kuntz Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
11. H.P. Schultheiss, E. Grube, K.H. Kuck, M.J. Suttorp, H. Heuer, H. Bonnier, J.J. Popma, R.E. Kuntz, J. Fadajet, and W. Wijns Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry Eurointervention 3 2007 76 81
12. D.E. Kandzari, M.B. Leon, J.J. Popma, P.J. Fitzgerald, C. O'Shaughnessy, M.W. Ball, M. Turco, R.J. Applegate, P.A. Gurbel, M.G. Midei, S.S. Badre, L. Mauri, K.P. Thompson, L.A. LeNarz, and R.E. Kuntz Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial J Am Coll Cardiol 48 2006 2440 2447 (Pubitemid 44881222)
13. M.B. Leon, L. Mauri, J.J. Popma, D.E. Cutlip, E. Nikolsky, C. O'Shaughnessy, P.A. Overlie, B.T. McLaurin, S.L. Solomon, J.S. Douglas Jr, M.W. Ball, R.P. Caputo, A. Jain, T.R. Tolleson, B.M. Reen III, A.J. Kirtane, P.J. Fitzgerald, K. Thompson, and D.E. Kandzari A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial J Am Coll Cardiol 55 2010 543 554
14. T.L. Pinto Slottow, and R. Waksman Overview of the 2007 Food and Drug Administration circulatory system devices panel meeting on the Endeavor zotarolimus-eluting coronary stent Circulation 117 2008 1603 1608 (Pubitemid 351440648)
15. R. Sakurai, Y. Hongo, M. Yamasaki, Y. Honda, H.N. Bonneau, P.G. Yock, D. Cutlip, J.J. Popma, P. Zimetbaum, J. Fajadet, R.E. Kuntz, W. Wijns, and P.J. Fitzgerald Detailed intravascular ultrasound analysis of zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial) Am J Cardiol 100 2007 818 823
16. A. Miyazawa, J. Ako, Y. Hongo, S.H. Hur, I. Tsujino, B.K. Courtney, A.H. Hassan, D.E. Kandzari, Y. Honda, and P.J. Fitzgerald Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III Am Heart J 155 2008 108 113 (Pubitemid 350234763)
17. K. Waseda, A. Miyazawa, J. Ako, T. Hasegawa, I. Tsujino, R. Sakurai, P.G. Yock, Y. Honda, D.E. Kandzari, and M.B. Leon Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease PJ F J Am Coll Cardiol Intv 8 2009 779 784
18. T. Kataoka, E. Grube, Y. Honda, Y. Morino, S.H. Hur, H.N. Bonneau, A. Colombo, C. Di Mario, G. Guagliumi, K.E. Hauptmann, M.R. Pitney, A.J. Lansky, S.H. Stertzer, P.G. Yock, and P.J. Fitzgerald 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to Compare Restenosis Rate Between Quest and Quads-QP2 (SCORE) Circulation 106 2002 1788 1793
19. Y. Honda Drug-eluting stents Insights from invasive imaging technologies Circ J 73 2009 1371 1380
20. B.K. Slinker, and S.A. Glantz Multiple linear regression: accounting for multiple simultaneous determinants of a continuous dependent variable Circulation 117 2008 1732 1737 (Pubitemid 351482596)
21. M. Crilly, P. Bundred, X. Hu, L. Leckey, and F. Johnstone Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care BMC Health Serv Res 7 2007 142
22. H. Jneid, G.C. Fonarow, C.P. Cannon, A.F. Hernandez, I.F. Palacios, A.O. Maree, Q. Wells, B. Bozkurt, K.A. Labresh, L. Liang, Y. Hong, L.K. Newby, G. Fletcher, E. Peterson, and L. Wexler Sex differences in medical care and early death after acute myocardial infarction Circulation 118 2008 2803 2810
23. C. Daly, F. Clemens, J.L. Lopez Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, W. Ruzyllo, K. Thygesen, F. Verheugt, and K.M. Fox Gender differences in the management and clinical outcome of stable angina Circulation 113 2006 490 498
24. V. Novack, D.E. Cutlip, A. Jotkowitz, N. Lieberman, and A. Porath Reduction in sex-based mortality difference with implementation of new cardiology guidelines Am J Med 121 2008 597 603
25. R.A. Brown, M. Williams, C.M. Barker, L. Mauri, I.T. Meredith, J. Fajadet, W. Wijns, M.B. Leon, and D.E. Kandzari Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results Catheter Cardiovasc Interv 76 2010 804 813
26. Y.W. Chen, M.L. Smith, M. Sheets, S. Ballaron, J.M. Trevillyan, S.E. Burke, T. Rosenberg, C. Henry, R. Wagner, J. Bauch, K. Marsh, T.A. Fey, G. Hsieh, D. Gauvin, K.W. Mollison, G.W. Carter, and S.W. Djuric Zotarolimus, a novel sirolimus analogue with potent anti-proliferative activity on coronary smooth muscle cells and reduced potential for systemic immunosuppression J Cardiovasc Pharmacol 49 2007 228 235 (Pubitemid 46626015)
27. J.E. Sousa, M.A. Costa, A.C. Abizaid, B.J. Rensing, A.S. Abizaid, L.F. Tanajura, K. Kozuma, G. Van Langenhove, A.G. Sousa, R. Falotico, J. Jaeger, J.J. Popma, and P.W. Serruys Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 2001 2007 2011 (Pubitemid 33027038)
28. B.D. Klugherz, G. Llanos, W. Lieuallen, G.A. Kopia, G. Papandreou, P. Narayan, B. Sasseen, S.J. Adelman, R. Falotico, and R.L. Wilensky Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent Coron Artery Dis 13 2002 183 188 (Pubitemid 34747967)
29. S. Silber, and E. Grube The Boston Scientific antiproliferative, paclitaxel eluting stents (TAXUS) P. Serruys, M. Kutryk, Handbook of Coronary Stents 4th ed. 2001 Martin Dunitz Publishers Ltd London, UK 311 319
30. A.J. Lansky, J.S. Hochman, P.A. Ward, G.S. Mintz, R. Fabunmi, P.B. Berger, G. New, C.L. Grines, C.G. Pietras, M.J. Kern, M. Ferrell, M.B. Leon, R. Mehran, C. White, J.H. Mieres, J.W. Moses, G.W. Stone, and A.K. Jacobs Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association Circulation 111 2005 940 953 (Pubitemid 40282597)